Lab
Laboratorio Clinico Delgado Amador, PSC
Laboratorio Clinico Delgado Amador, PSC was paid $1.48M by Medicaid between Jan 2018 and Nov 2024, across 57 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 15% of everything it billed.
33Billing provider infoLABORATORIO CLINICO DELGADO AMADOR, PSC
CAMUY, PR 00627
CAMUY, PR 00627
33aNPI1730352634assigned 04/11/2008
33bProvider typeClinical Medical Laboratory
28Total paid$1.48M
24GClaims121,608
24DCodes billed57
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#81 of 777
Median peer was paid$278K
This provider vs. median5.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,294 | $129K | |
| 2019 | 8,846 | $82K | |
| 2020 | 10,332 | $104K | |
| 2021 | 19,819 | $293K | |
| 2022 | 21,670 | $357K | |
| 2023 | 24,278 | $278K | |
| 2024incomplete | 22,369 | $240K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 15% | 5,313 | 4,795 | $219K |
| 84443 | Thyroid stimulating hormone (TSH) | 11% | 10,926 | 10,532 | $170K |
| 80061 | Lipid panel | 8.7% | 10,175 | 9,816 | $129K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 8.3% | 5,144 | 4,576 | $123K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.2% | 16,772 | 15,618 | $121K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 7.9% | 4,292 | 4,136 | $117K |
| 80053 | Comprehensive metabolic panel | 7.4% | 11,255 | 10,757 | $110K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.8% | 6,089 | 5,865 | $56K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.5% | 2,797 | 2,268 | $52K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.6% | 764 | 707 | $38K |
| 81000 | 2.5% | 12,381 | 11,850 | $37K | |
| 82274 | 2.4% | 2,327 | 2,237 | $35K |
45 more codes
| 84439 | 2.1% | 3,318 | $31K | |
| 84153 | 1.6% | 1,398 | $24K | |
| 86738 | 1.6% | 1,784 | $23K | |
| 82607 | 1.4% | 1,401 | $20K | |
| 80074 | 1.3% | 415 | $19K | |
| 86328 | 1.3% | 756 | $19K | |
| 82043 | 1.3% | 3,210 | $19K | |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 4,666 | $18K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.0% | 1,913 | $15K |
| 86701 | 1.0% | 1,642 | $15K | |
| 87088 | <1% | 1,291 | $10K | |
| 84436 | <1% | 1,516 | $9K | |
| 84479 | <1% | 1,541 | $8K | |
| 86592 | <1% | 1,470 | $6K | |
| 85651 | <1% | 1,632 | $5K | |
| 82570 | <1% | 1,103 | $5K | |
| 87590 | <1% | 236 | $5K | |
| 87490 | <1% | 236 | $4K | |
| 84550 | <1% | 1,042 | $4K | |
| 83001 | <1% | 142 | $3K | |
| 85730 | <1% | 311 | $2K | |
| 86803 | <1% | 138 | $2K | |
| 86038 | <1% | 130 | $1K | |
| 86140 | <1% | 322 | $1K | |
| 85610 | <1% | 354 | $1K | |
| 82378 | <1% | 56 | $1K | |
| 82947 | <1% | 151 | $557.54 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 79 | $556.09 |
| 83655 | <1% | 41 | $511.69 | |
| 80050 | General health panel | <1% | 45 | $443.15 |
| 86376 | <1% | 29 | $415.64 | |
| 82670 | <1% | 12 | $327.30 | |
| 84481 | <1% | 18 | $297.63 | |
| 80076 | <1% | 36 | $249.47 | |
| 84146 | <1% | 12 | $230.58 | |
| 86696 | <1% | 12 | $213.72 | |
| 87177 | <1% | 24 | $206.56 | |
| 86695 | <1% | 12 | $147.01 | |
| 82950 | <1% | 14 | $59.36 | |
| 82270 | <1% | 13 | $46.02 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 765 | $0.00 |
| 3050F | 0% | 13 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 19 | $0.00 |
| 3044F | 0% | 18 | $0.00 | |
| 3048F | 0% | 37 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAMADOR, SAHUDY (PRESIDENT)